IsoPlexis Selects FlowMetric Life Sciences, Inc. as a Certified Service Provider of IsoPlexis’ Unique Functional Proteomics

IsoPlexis Partners with FlowMetric to Provide Combined Single-Cell Proteomic and Flow Cytometric Solutions

FlowMetric Life Sciences, Inc., a global leader in Flow Cytometry services, was recently named a Certified Service Provider of the IsoPlexis technology. As a Certified Service Provider, FlowMetric can provide IsoPlexis’ single-cell and ultra-small sample volume proteomics services to its customers, complementing the Flow Cytometry solutions offered by the company. FlowMetric is the first Contract Research Organization (CRO) on the east coast to offer the full array of IsoPlexis’ products, including the IsoCode and CodePlex assays for research in the fields of cancer immunology, inflammation, vaccine development, infectious diseases, and cell and gene therapy.

Established in Doylestown, PA in 2010, Flowmetric Life Sciences, Inc. is committed to improving lives with state-of-the-are flow cytometry techniques and a dedication to “scientific expertise, integrity, innovation, and people.” A globally recognized CRO, FlowMetric works with partners in several areas such as biotechnology companies, pharmaceutical companies, hospitals, and academic research institutions.

Through this partnership, FlowMetric and IsoPlexis hope to help clients define key biological drivers and make critical scientific discoveries. IsoPlexis’ platform can help researchers overcome significant research challenges through single-cell proteomics, enabling groundbreaking discoveries and facilitating the development of effective therapeutics or vaccines. IsoPlexis’ Certified Service Providers are at the top of their fields, helping researchers illuminate the underlying drivers of complex disease to accelerate research and medicine.

Learn more about becoming a Certified Service Provider here and read the recent press release here.

Share This Article
Subscribe to Follow the Data

Weekly email to keep you at the forefront of single-cell & multiplexed proteomics.